70 likes | 85 Views
Explore the intricate relationship between insulin therapy and vascular function in diabetes care. Learn about the beneficial and adverse effects, along with effective strategies for patient care. Presented by Dr. Stanley Schwartz, this evidence-based session sheds light on the logic for new approaches. Discover the latest insights for better management of diabetes.
E N D
Insulin Therapy & Vascular Function : Logic for New Approaches to Diabetes Care:A Translational and Evidence-Based Practice Interpretation Stan Schwartz MD, FACP, FACE Affiliate Main Line Health Emeritus, Clinical Assoc. Prof. Medicine Univ of Pa. stschwar@gmail.com
Presenter Disclosure Information In compliance with the accrediting board policies, the American Diabetes Association requires the following disclosure to the participants: Stanley Schwartz Research Support: 0 Employee: 0 Board Member/Advisory Panel: Janssen, Merck, AZ-BMS, BI-Lilly, Salix, Novo, Genesis Biotechnology Group Stock/Shareholder: Saturn EMR Decision Support APP. Consultant: NIH RO1 DK085212, Struan Grant PI Other: Speaker’s Bureaus: Janssen, Merck, Novo, Salix, BI-LILLY, Eisai, AZ-Int’l, Amgen
Is Insulin Beneficial for the Vasculature (and the Patient) or NOT ??
Normal Physiology of Insulin re: The Vasculature;Counteracting Transient Oxidative Stress of Feeding Dandona P, Aljada A, Mohanty P. Diabetologia. 2002 Jun;45:924-30.
At Normal Insulin Concentrations:Benefits on Vasculature Many Still use as argument for Early Insulin Therapy in Diabetes BUT!! Circulation. 2005;111:1448-1454. Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation, Paresh Dandona
At Abnormal Insulin Concentrations- Hyperinsulinism :Adverse Effects on Vasculature Even Dandona appreciated the Adverse Effects of Insulin Circulation. 2005;111:1448-1454. Metabolic Syndrome A Comprehensive Perspective Based on Interactions Between Obesity, Diabetes, and Inflammation,Paresh Dandona
Balance of Insulin Effects Mechanisms of Disease: pathway-selective insulin resistance and microvascular complications of diabetes Per-Henrik Groop*, NATURE CLINICAL PRACTICE ENDOCRINOLOGY & METABOLISM DECEMBER 2005 VOL 1 NO 2